<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药春秋 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-24T23:23:09+08:00</updated>
  <subtitle>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>最具潜力药品Top 10出炉，PD-1/L1强势依旧！</title>
    <updated>2020-11-24T21:37:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/LKnmooaZPs-Ih3UfsDnopA</id>
    <link href="https://mp.weixin.qq.com/s/LKnmooaZPs-Ih3UfsDnopA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产「药王」新适应症获批，八成原研市场进一步被瓜分</title>
    <updated>2020-11-24T21:37:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/dAqNXMR461xqspVZUVsxGA</id>
    <link href="https://mp.weixin.qq.com/s/dAqNXMR461xqspVZUVsxGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4+7集采扩容续约，最新消息公布！</title>
    <updated>2020-11-24T21:37:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/oJpEQttxzer07t8OMcSS8A</id>
    <link href="https://mp.weixin.qq.com/s/oJpEQttxzer07t8OMcSS8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>两批参比目录最新发布，187个新增、15个变更...</title>
    <updated>2020-11-24T21:37:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/JhXHmuQUbd7wedPX1shWTQ</id>
    <link href="https://mp.weixin.qq.com/s/JhXHmuQUbd7wedPX1shWTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>（2020.11.23）最新一致性评价目录，3品种决出首家！</title>
    <updated>2020-11-23T21:45:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/tCZhgLoLcuh1hQKJ66kN_w</id>
    <link href="https://mp.weixin.qq.com/s/tCZhgLoLcuh1hQKJ66kN_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保支付与集采协同，50个药品自负比例提高10~20%！</title>
    <updated>2020-11-23T21:45:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/yn1ZuUfiI0TQY6mN6DjeKg</id>
    <link href="https://mp.weixin.qq.com/s/yn1ZuUfiI0TQY6mN6DjeKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“原料药垄断”决定书——处罚高达247万元！</title>
    <updated>2020-11-23T21:45:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/eNK9qOCuDwwhdgOfpTYT5Q</id>
    <link href="https://mp.weixin.qq.com/s/eNK9qOCuDwwhdgOfpTYT5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>未过评品种集采来袭，注射剂成主力军</title>
    <updated>2020-11-23T21:45:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/aLGsv3vQzfnyZ-lZS5NbuQ</id>
    <link href="https://mp.weixin.qq.com/s/aLGsv3vQzfnyZ-lZS5NbuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布：化药I期临床试验相关技术要求及研究信息汇总</title>
    <updated>2020-11-23T21:45:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/JfLPucSgppB_XNdxMiK1qQ</id>
    <link href="https://mp.weixin.qq.com/s/JfLPucSgppB_XNdxMiK1qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多肽的机遇，藏在不同的治疗领域！</title>
    <updated>2020-11-22T09:06:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/7XO6LX7etFQsUqwgKyCr8A</id>
    <link href="https://mp.weixin.qq.com/s/7XO6LX7etFQsUqwgKyCr8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采推动，降糖类药物加速迭代，行业老大如何突破？</title>
    <updated>2020-11-20T21:38:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/l6zOBSHPshH2k_T4kTvnFg</id>
    <link href="https://mp.weixin.qq.com/s/l6zOBSHPshH2k_T4kTvnFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>两种情况，药品可在临床阶段，附条件获批！</title>
    <updated>2020-11-20T21:38:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/dfrwdeuuWojcYefnBBAcvw</id>
    <link href="https://mp.weixin.qq.com/s/dfrwdeuuWojcYefnBBAcvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一批药品联动降价，平均降幅达57%！</title>
    <updated>2020-11-20T21:38:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/TWSNwFVrpidw9di7n7O5rQ</id>
    <link href="https://mp.weixin.qq.com/s/TWSNwFVrpidw9di7n7O5rQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今天，17个注射剂集采开启报量</title>
    <updated>2020-11-20T21:38:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/czXuX0q9eMdTdmOHWokP2w</id>
    <link href="https://mp.weixin.qq.com/s/czXuX0q9eMdTdmOHWokP2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>（2020.11.19）最新一致性评价名单；首家过评品种占比高达80%！</title>
    <updated>2020-11-19T21:38:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/_QDOtR0rpIaIbIsg1vZCcA</id>
    <link href="https://mp.weixin.qq.com/s/_QDOtR0rpIaIbIsg1vZCcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>知名重磅注射液，8家企业相继降价！</title>
    <updated>2020-11-19T21:38:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/DsdSnA5iVPZAyco6JIjmIg</id>
    <link href="https://mp.weixin.qq.com/s/DsdSnA5iVPZAyco6JIjmIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第三批国采：27省市执行时间已敲定</title>
    <updated>2020-11-19T21:38:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/CbcvaV2p30i9cpUNoQdrKg</id>
    <link href="https://mp.weixin.qq.com/s/CbcvaV2p30i9cpUNoQdrKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>院内医保制剂申报，这些情况明确不准纳入！</title>
    <updated>2020-11-19T21:38:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/ICc02TmWBVRfHWkbVknrUA</id>
    <link href="https://mp.weixin.qq.com/s/ICc02TmWBVRfHWkbVknrUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，十个最受关注的抗癌药（附销售数据预测）</title>
    <updated>2020-11-18T21:38:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/4zvSnnClAEPgwbT-h2xneA</id>
    <link href="https://mp.weixin.qq.com/s/4zvSnnClAEPgwbT-h2xneA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>磷酸西格列汀：国内首个备案（A）的进口原料药获批</title>
    <updated>2020-11-18T21:38:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/uOw38FO5VYA-drjc5pFzJg</id>
    <link href="https://mp.weixin.qq.com/s/uOw38FO5VYA-drjc5pFzJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>